Workstream Patients

Respiratory conditions are abundant, on the rise and have a major impact on the quality of life of patients

More than 1 in 4 people suffer from chronic illnesses. A staggering 75% of healthcare spending in Europe is linked to managing chronic conditions. Integrated care implies coordination and strong collaboration among healthcare actors, from primary care to rehabilitation, with the patients’ needs placed at the center.

The goal is to provide higher quality care, improved health outcomes, and better patient experience within the care journey.

Reach out and get in touch

Integrated Care for a better Health

Policymakers and stakeholders are well aware of the importance of integrated care. In 2015, the ministers responsible for public health at regional and federal level in Belgium adopted a common plan to tackle chronic disease, entitled “Integrated Care for a better Health”. A series of pilot projects have been set up in the meantime, and the new government agreement refers explicitly to integrated care.

Through a series of targeted roundtables, the workstream aims to come to a set of recommendations that will be handed over to the medical societies and the world of politics for further discussion, refinement, dissemination and ultimately implementation to the benefit of Belgian patients.

Today, the workstream focuses on 3 specific lung diseases: asthma, COPD and diseases triggered by an underlying type-2 inflammation.

Our experts

Frank Pieters, CEO P&L Projects, chairman of the board at Softhale NV, head of strategy and business development at Aquilon.

Downloads

My Pulmonary Research: Prof. dr. Ken Bracke, Ghent University, on inhibition of regulated cell death

Towards novel therapeutic approaches in COPD

My Pulmonary Research: dr. Janne Goossens, Idewe & KU Leuven, on preventing and treating chronic respiratory diseases

Leveraging Digital Technology

The emissions from constructions and renovations in hospitals can have several negative impacts on the air quality, affecting the patients' health.

Point of View 'Patients suffer from constructions in and near hospitals'

The health of individuals attending an environment in a health institution is closely related to the quality of the air they breathe. How can hospitals improve air quality and patients' health by integrating cutting-edge air decontamination technologies?

Point of View 'Modern hospitals should focus more on air purification.'

A 3rd roundtable discussion was held to discuss the results of a survey held at the level of HealthCare Professionals and Patients, carried out by Medistrat.

Proceedings Type 2 Inflammation - Roundtable III

On the occasion of World Asthma Day today 4 May 2021, we highlight the importance and the extensiveness of the survey outcomes, in our pursuit of an adequate solution to the problems it reveals: a national asthma plan.

Belgium In Urgent Need Of A National Asthma Plan

A roundtable discussion was held to position the work and set expectations. It addressed the scientific case for collaboration around type 2 inflammation diseases. You can find the proceedings here. Want to read more? Join eu.reca today!

Proceedings Type 2 Inflammation - Roundtable II

At the time when Covid was still being dismissed as just a mild flu in Belgium, large international companies were already taking drastic measures to protect their employees and ensure continuity of production.

Point of View 'Umicore: International cooperation allows us to keep a step ahead of the pandemic'

The SARS-CoV-2 virus can cause severe pneumonia which is different from other pneumonia common seen in the hospital.

Point of View 'COVID-19, a special case'

The new pandemic of viral disease should not have come unexpectedly. Indeed, in the last decades, the world was under threat of a new pandemic several times.

Point of View 'COVID-19, Where do we go'

In the past, several waves of contagious diseases have threatened humankind. Sometimes on a large scale, others more on a local scale but the pattern still comes back.

Point of View 'COVID-19, what we can learn from history'

How does COVID-19 impact the business of a young and innovative spin-off company active in lung disease assessment?

Point of View 'ArtiQ: AI is making a difference in lung disease assessment'

A roundtable discussion was held – focused on the Multidisciplinary Care Model in hospitals You can find the proceedings here.

Proceedings Type 2 Inflammation Roundtable I

The innovation needs in the respiratory sector are real and acute. We are therefore happy that so many young and promising companies strive to find the necessary solutions.

Pulmonary Innovation Forum

All news

Workstream sponsors

Sanofi

Sanofi is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused on human health. We prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. We stand by the few who suffer from rare diseases and the millions with long-term chronic conditions.

With more than 100,000 people in 100 countries, Sanofi is transforming scientific innovation into healthcare solutions around the globe. Sanofi, Empowering Life.

VRGT

The VRGT is an organisation passionate about the human lung and working hard to defeat lung diseases. Our mission? To be the centre of expertise regarding TBC, but also to be a key player in respiratory health with a focus on encouraging and helping people to quit smoking.

BeRS

The Belgian Respiratory Society (BeRS) is a scientific association of doctors, nurses, physiotherapists and scientific researchers with an interest in the field of lung diseases. The primary objectives of the BeRS are to promote respiratory health and to combat respiratory diseases in Belgium.